+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Chronic Pain Drug"

Chronic Pain -Epidemiology Forecast -2032 - Product Thumbnail Image

Chronic Pain -Epidemiology Forecast -2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
US Chronic Pain Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Chronic Pain Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
From
From
Visceral Pain - Pipeline Review, H2 2018 - Product Thumbnail Image

Visceral Pain - Pipeline Review, H2 2018

  • Drug Pipelines
  • August 2018
  • 113 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Analgesics are a class of drugs used to treat chronic pain. They work by blocking pain signals from reaching the brain, reducing inflammation, and providing relief from pain. Common analgesics include non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and acetaminophen. NSAIDs are the most commonly prescribed analgesics, and are used to treat a variety of conditions, including arthritis, headaches, and muscle pain. Opioids are powerful painkillers that are used to treat severe pain, such as cancer pain. Acetaminophen is a milder analgesic that is used to treat mild to moderate pain. The chronic pain drug market is a rapidly growing sector of the pharmaceutical industry. It is driven by the increasing prevalence of chronic pain conditions, such as arthritis, fibromyalgia, and neuropathic pain. The market is also driven by the development of new and improved analgesics, such as opioid-based painkillers and non-opioid alternatives. Some companies in the chronic pain drug market include Pfizer, Johnson & Johnson, Merck, GlaxoSmithKline, Novartis, and Eli Lilly. Show Less Read more